21-09-2025, 09:16

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Notified -
Globe Newswire21-09-2025, 09:16
31-05-2025, 08:05

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Notified -
Globe Newswire31-05-2025, 08:05
2-11-2024, 02:05

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Globe Newswire2-11-2024, 02:05